93 related articles for article (PubMed ID: 18483139)
1. Optimal (57)Co flood source activity and acquisition time for lymphoscintigraphy localization images.
Mar MV; Dickinson RL; Erwin WD; Wendt RE
J Nucl Med Technol; 2008 Jun; 36(2):82-7. PubMed ID: 18483139
[TBL] [Abstract][Full Text] [Related]
2. Reducing exposure from 57Co sources during breast lymphoscintigraphy by optimizing energy windows and other suggested enhancements of acquisition and the display of images.
Krynyckyi BR; Sata S; Zolty I; Kim CK; Knesaurek K
J Nucl Med Technol; 2004 Dec; 32(4):198-205. PubMed ID: 15576341
[TBL] [Abstract][Full Text] [Related]
3. Transmission Imaging in Lymphoscintigraphy with a 153Gd Flood Source.
DiFilippo FP; Brunken RC; Neumann DR
J Nucl Med Technol; 2015 Dec; 43(4):253-60. PubMed ID: 26338486
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of mammary lymphoscintigraphy by a single intratumoral injection for sentinel node identification.
Valdés-Olmos RA; Jansen L; Hoefnagel CA; Nieweg OE; Muller SH; Rutgers EJ; Kroon BB
J Nucl Med; 2000 Sep; 41(9):1500-6. PubMed ID: 10994729
[TBL] [Abstract][Full Text] [Related]
5. Use of low-dose technetium Tc 99m sulfur colloid to locate sentinel lymph nodes in melanoma of the head and neck: preliminary study.
Rasgon BM
Laryngoscope; 2001 Aug; 111(8):1366-72. PubMed ID: 11568570
[TBL] [Abstract][Full Text] [Related]
6. Patient effective dose from sentinel lymph node lymphoscintigraphy in breast cancer: a study using a female humanoid phantom and thermoluminescent dosemeters.
Law M; Cheng KC; Wu PM; Ho WY; Chow LW
Br J Radiol; 2003 Nov; 76(911):818-23. PubMed ID: 14623784
[TBL] [Abstract][Full Text] [Related]
7. Whole-body lymphoscintigraphy using transmission scans.
Vallejo Mar M; Gee-Johnson S; Kim EE; Podoloff DA
J Nucl Med Technol; 2002 Mar; 30(1):12-7. PubMed ID: 11948261
[TBL] [Abstract][Full Text] [Related]
8. Improved body-outline imaging technique for localization of sentinel lymph nodes in breast surgery.
Clarke E; Notghi A; Harding K
J Nucl Med; 2002 Sep; 43(9):1181-3. PubMed ID: 12215556
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of medium-energy collimator for sentinel node lymphoscintigraphy imaging in breast cancer patients.
Tsushima H; Takayama T; Yamanaga T; Kizu H; Shimonishi Y; Kosakai K; Noguchi A; Onoguchi M
J Nucl Med Technol; 2006 Sep; 34(3):153-9. PubMed ID: 16951284
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting sentinel node localization during preoperative breast lymphoscintigraphy.
Haigh PI; Hansen NM; Giuliano AE; Edwards GK; Ye W; Glass EC
J Nucl Med; 2000 Oct; 41(10):1682-8. PubMed ID: 11037998
[TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph node scintigraphy in cutaneous melanoma using a planar calibration phantom filled with Tc-99m pertechnetate solution for body contouring.
Peştean C; Bărbuş E; Piciu A; Larg MI; Sabo A; Moisescu-Goia C; Piciu D
Clujul Med; 2016; 89(4):480-485. PubMed ID: 27857516
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of nonvisualized sentinel lymph nodes in unselected breast cancer patients during lymphoscintigraphy.
Lo YF; Hsueh S; Ma SY; Chen SC; Chen MF
Chang Gung Med J; 2005 Jun; 28(6):378-86. PubMed ID: 16124153
[TBL] [Abstract][Full Text] [Related]
13. The impact of superficial injections of radiocolloids and dynamic lymphoscintigraphy on sentinel node identification in oral cavity cancer: a same-day protocol.
Tartaglione G; Vigili MG; Rahimi S; Celebrini A; Pagan M; Lauro L; Al-Nahhas A; Rubello D
Nucl Med Commun; 2008 Apr; 29(4):318-22. PubMed ID: 18317294
[TBL] [Abstract][Full Text] [Related]
14. Successful internal mammary visualization with periareolar injections of Tc-99m antimony sulfur colloid in sentinel node breast lymphoscintigraphy.
Ting AC; Cumarasingam B; Szeto ER
Clin Nucl Med; 2006 Oct; 31(10):593-7. PubMed ID: 16985361
[TBL] [Abstract][Full Text] [Related]
15. Technical aspects of sentinel node lymphoscintigraphy for breast cancer.
Dunnwald LK; Mankoff DA; Byrd DR; Anderson BO; Moe RE; Yeung RS; Eary JF
J Nucl Med Technol; 1999 Jun; 27(2):106-11. PubMed ID: 10353106
[TBL] [Abstract][Full Text] [Related]
16. Nonvisualization of axillary sentinel node during lymphoscintigraphy: is there a pathologic significance in breast cancer?
Brenot-Rossi I; Houvenaeghel G; Jacquemier J; Bardou VJ; Martino M; Hassan-Sebbag N; Pasquier J
J Nucl Med; 2003 Aug; 44(8):1232-7. PubMed ID: 12902412
[TBL] [Abstract][Full Text] [Related]
17. Temporary shielding of hot spots in the drainage areas of cutaneous melanoma improves accuracy of lymphoscintigraphic sentinel lymph node diagnostics.
Maza S; Valencia R; Geworski L; Zander A; Dräger E; Winter H; Sterry W; Munz DL
Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1399-402. PubMed ID: 12271426
[TBL] [Abstract][Full Text] [Related]
18. Comparison of different injection sites of radionuclide for sentinel lymph node detection in breast cancer: single institution experience.
Mudun A; Sanli Y; Ozmen V; Turkmen C; Ozel S; Eroglu A; Igci A; Yavuz E; Tuzlali S; Muslumanoglu M; Cantez S
Clin Nucl Med; 2008 Apr; 33(4):262-7. PubMed ID: 18356664
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of three lymphoscintigraphic agents in patients with cutaneous melanoma.
Glass EC; Essner R; Morton DL
J Nucl Med; 1998 Jul; 39(7):1185-90. PubMed ID: 9669391
[TBL] [Abstract][Full Text] [Related]
20. A lesion detection observer study comparing 2-dimensional versus fully 3-dimensional whole-body PET imaging protocols.
Lartizien C; Kinahan PE; Comtat C
J Nucl Med; 2004 Apr; 45(4):714-23. PubMed ID: 15073270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
